Evidence map›Paper›PMID 27882351›Full record

ArticleJCI insight2016

Activity of Na

Benjamin Schattling, Walid Fazeli, Birgit Engeland, Yuanyuan Liu, Holger Lerche, Dirk Isbrandt, Manuel A Friese

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. DecipheringArXiv · 2024
    Article
  8. Article
  9. The neuropathobiology of multiple sclerosis.Nature reviews. Neuroscience · 2024
    Review
  10. Aberrant hippocampal CabioRxiv : the preprint server for biology · 2024
    Article
  11. Dependence of cortical neuronal strength-duration properties on TMS pulse shape.Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2023
    Article
  12. Blockers of Skeletal Muscle NaInternational journal of molecular sciences · 2023
    Review
  13. Article
  14. Neuronal Adenosine AFrontiers in cellular neuroscience · 2022
    Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Benjamin SchattlingInstitut für Neuroimmunologie und Multiple Sklerose, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Walid FazeliInstitut für Molekulare und Verhaltensneurowissenschaften, Universität zu Köln, Köln, Germany.
Birgit EngelandInstitut für Molekulare und Verhaltensneurowissenschaften, Universität zu Köln, Köln, Germany.
Yuanyuan LiuAbteilung Neurologie mit Schwerpunkt Epileptologie, Hertie-Institut für klinische Hirnforschung, Universitätsklinikum Tübingen, Tübingen, Germany.
Holger LercheAbteilung Neurologie mit Schwerpunkt Epileptologie, Hertie-Institut für klinische Hirnforschung, Universitätsklinikum Tübingen, Tübingen, Germany.
Dirk IsbrandtInstitut für Molekulare und Verhaltensneurowissenschaften, Universität zu Köln, Köln, Germany.
Manuel A FrieseInstitut für Neuroimmunologie und Multiple Sklerose, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
German Center for Neurodegenerative Diseases · DEUniversität Hamburg · DEUniversity Medical Center Hamburg-Eppendorf · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Counteracting the progressive neurological disability caused by neuronal and axonal loss is the major unmet clinical need in multiple sclerosis therapy. However, the mechanisms underlying irreversible neuroaxonal degeneration in multiple sclerosis and its animal model experimental autoimmune encephalomyelitis (EAE) are not well understood. A long-standing hypothesis holds that the distribution of voltage-gated sodium channels along demyelinated axons contributes to neurodegeneration by increasing neuroaxonal sodium influx and energy demand during CNS inflammation. Here, we tested this hypothesis in vivo by inserting a human gain-of-function mutation in the mouse Na

Indexed as

Gain of Function MutationAnimalsAxonsEncephalomyelitis, Autoimmune, ExperimentalGene Knock-In TechniquesHumansMiceMice, Inbred C57BLMultiple SclerosisNAV1.2 Voltage-Gated Sodium ChannelNerve DegenerationNAV1.2 Voltage-Gated Sodium Channel

Identifiers

PMID27882351
PMCPMC5111507
OpenAlexW2554819882

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.